RPRX
Royalty Pharma plc
NASDAQ · Healthcare · Biotechnology · US
$63.96
+0.13%Leverage
- Debt / equity
- 1.31x
- Net debt / equity
- 1.19x
- Debt / assets
- 0.45x
- Debt / EBITDA
- 5.22x
- Net debt / EBITDA
- 4.75x
Liquidity & coverage
- Current ratio
- 1.29x
- Quick ratio
- 1.29x
- Cash ratio
- 1.33x
- Interest coverage
- 4.38x
- EBITDA / interest
- 4.75x
- Working capital
- $181.1M
Cash & dividend
- FCF / debt
- 0.33x
- Cash flow / debt
- 0.33x
- Dividend per share
- $0.92
- Dividend yield
- 1.4%
- Dividend growth 1y
- +4.8%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026